Scientists at Rutgers and other universities build technology that could lead to rapid discovery of new medicines and biomarkers hidden in genomes
Discovering the function of a gene requires cloning a DNA sequence and expressing it. Until now, this was performed on a one-gene-at-a-time basis, causing a bottleneck. Scientists at Rutgers University-New Brunswick in collaboration with Johns Hopkins University and Harvard Medical School have invented a technology to clone thousands of genes simultaneously and create massive libraries of proteins from DNA samples, potentially ushering in a new era of functional genomics.
“We think that the rapid, affordable, and high-throughput cloning of proteins and other genetic elements will greatly accelerate biological research to discover functions of molecules encoded by genomes and match the pace at which new genome sequencing data is coming out,” said Biju Parekkadan, an associate professor in the Department of Biomedical Engineering at Rutgers University-New Brunswick.
In a study published online today in the journal Nature Biomedical Engineering, the researchers showed that their technology – LASSO (long-adapter single-strand oligonucleotide) probes – can capture and clone thousands of long DNA fragments at once.
As a proof-of-concept, the researchers cloned more than 3,000 DNA fragments from E. coli bacteria, commonly used as a model organism with a catalogued genome sequence available.
“We captured about 95 percent of the gene targets we set out to capture, many of which were very large in DNA length, which has been challenging in the past,” Parekkadan said. “I think there will certainly be more improvements over time.”
They can now take a genome sequence (or many of them) and make a protein library for screening with unprecedented speed, cost-effectiveness and precision, allowing rapid discovery of potentially beneficial biomolecules from a genome.
In conducting their research, they coincidentally solved a longstanding problem in the genome sequencing field. When it comes to genetic sequencing of individual genomes, today’s gold standard is to sequence small pieces of DNA one by one and overlay them to map out the full genome code. But short reads can be hard to interpret during the overlaying process and there hasn’t been a way to sequence long fragments of DNA in a targeted and more efficient way. LASSO probes can do just this, capturing DNA targets of more than 1,000 base pairs in length where the current format captures about 100 base pairs.
The team also reported the capture and cloning of the first protein library, or suite of proteins, from a human microbiome sample. Shedding light on the human microbiome at a molecular level is a first step toward improving precision medicine efforts that affect the microbial communities that colonize our gut, skin and lungs, Parekkadan added. Precision medicine requires a deep and functional understanding, at a molecular level, of the drivers of healthy and disease-forming microbiota.
Today, the pharmaceutical industry screens synthetic chemical libraries of thousands of molecules to find one that may have a medicinal effect, said Parekkadan, who joined Rutgers’ School of Engineering in January.
“Our vision is to apply the same approach but rapidly screen non-synthetic, biological or ‘natural’ molecules cloned from human or other genomes, including those of plants, animals and microbes,” he said. “This could transform pharmaceutical drug discovery into biopharmaceutical drug discovery with much more effort.”
The next phase, which is underway, is to improve the cloning process, build libraries and discover therapeutic proteins found in our genomes, Parekkadan said.
The Latest on: Precision medicine
- Regeneron and CCPM collaborate to advance human genetics, precision medicineon May 11, 2020 at 4:16 pm
Regeneron Pharmaceuticals, Inc. and the Colorado Center for Personalized Medicine at the University of Colorado Anschutz Medical Campus today announced a large-scale research collaboration designed to ...
- Analyzing the Role of Pharmacovigilance Analytics for German Precision Medicine Market | A Quantzig Success Storyon May 11, 2020 at 11:18 am
Considering the growing complexities around drug development and drug safety, pharmacovigilance departments within the precision medicine market must have in place a robust process to identify risks ...
- “Direct to Drug” screening as a precision medicine tool in multiple myelomaon May 11, 2020 at 8:54 am
Seventy-six FDA-approved oncology drugs and emerging therapeutics were evaluated in 25 multiple myeloma (MM) and 15 non-Hodgkin’s lymphoma cell lines and in 113 primary MM samples. Ex vivo drug ...
- Precision Medicine Market is set to face heavy demand in the market due to growing approval of personalized medicines from the regulatory authoritieson May 11, 2020 at 7:55 am
Data Bridge Market Research has added an exhaustive research study of the Global Precision Medicine Market detailing every single market driver and intricately analyzing the business vertical The ...
- Caris Life Sciences to Present Data Spotlighting Clinical Impact of Precision Medicine in ASCO20 Virtual Scientific Programon May 11, 2020 at 3:30 am
Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced ...
- Role of Pharmacovigilance in Precision Medicine Marketon May 8, 2020 at 6:13 am
Quantzig has announced the completion of its recent engagement- Pharmacovigilance: Improving Drug Development Amid The Covid-19 Crisis ...
- Cancer biomarker discovery for precision medicineon May 7, 2020 at 7:57 am
Christie Hunter, Director of Applications at SCIEX, discusses using proteomics in big data-driven precision medicine for the fight against prostate cancer.
- Precision public health may be the answer to COVID-19: Opinionon May 7, 2020 at 2:20 am
Instead of relying on a one-size-fits-all approach, we need to rapidly develop a precision public health approach to containing the virus. It should be centered on case finding (identifying people ...
- Precision Medicine Market 2019 Global Demand in Healthcare sector, Size, Share, Trends, Growth, revenue and Forecast 2026on May 6, 2020 at 1:10 am
Analytical Research Cognizance provides a research on the ' Precision Medicine market' which offers a concise summary pertaining ...
- Unnecessary Genetic Complexity Needs to be Unpacked to Advance Precision Medicineon May 5, 2020 at 2:25 pm
Two McMaster researchers find the promise of personalized medicine has not fully materialized because the full sophistication of the genetic blueprint has a more complex and far-reaching influence on ...
via Google News and Bing News